(Q33811516)

29 July 2017

1 reference

title

New and emerging therapies for vitiligo (English)

1 reference

29 July 2017

1 reference

Halder RM

1

1 reference

PubMed ID

10626114

29 July 2017

Young CM

series ordinal

2

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

18

1 reference

29 July 2017

1

1 reference

29 July 2017

79-89, ix

1 reference

Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Treatment of vitiligo with melanocytic grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Vitiligo: repigmentation with dermabrasion and thin split-thickness skin graft.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

A new model of epidermal culture for the surgical treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Melanocyte reservoir in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Modified Thiersch grafting in stable vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Repigmentation of vitiliginous skin by cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Overgrafting for leukoderma of the lower lip: a new application of an already established method

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Surgical combination therapy for vitiligo and piebaldism.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Surgical therapies for vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Mechanisms of phototherapy of vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Micropigmentation for the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Treatment of stable vitiligo with autologous epidermal grafting and PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Treatment of vitiligo with oral 5-methoxypsoralen

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Therapeutic success of epidermal grafting in generalized vitiligo is limited by the Koebner phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Vitiligo: treatment by dermabrasion and epithelial sheet grafting--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Grafting following short-pulse carbon dioxide laser de-epithelialization

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Vitiligo: treatment by dermabrasion and epithelial sheet grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Oral minipulse therapy in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Pigment cell transplantation for treatment of vitiligo: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Transplantation of melanocytes by epidermal grafting. An Indian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Suplatast tosilate (IPD), a new immunoregulator, is effective in vitiligo treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Melanocyte destruction and repopulation in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Transplantation of melanocytes in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Leucoderma treated by transplantation of a basal cell layer enriched suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

A surgical treatment for vitiligo: autologous cultured-epithelial grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Autografting and PUVA A Combination Therapy for Vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Vitiligo treatment with a combination of PUVA therapy and epidermal autografts

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

Successful treatment of vitiligo with PUVA-pigmented autologous epidermal grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970149-2

7 January 2021

10.1016/S0733-8635(05)70149-2

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10626114